Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Diabetes Management: Blood Glucose Monitoring Devices Market 2018 to 2023 - Profiling Abbott, Ascensia Diabetes Care, Dexcom & Medtronic Among Others - ResearchAndMarkets.com

February 4, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Feb 4, 2020--

The “Diabetes Management: Blood Glucose Monitoring Devices Market” report has been added to ResearchAndMarkets.com’s offering.

Valued at nearly $8bn in 2018, the global Blood Glucose Monitoring Devices (BGMDs) Market is growing at a fast pace - at a compound annual growth rate (CAGR) of approximately 11% - due to the phenomenal sales growth of new revolutionary CGMs, such as Abbott’s FreeStyle Libre and Dexcom’s G6 CGM.

The market is expected to total nearly $13bn by 2023. Growth of CGMs will be offset by a steady decline in the BGMs segment due to continued extreme price competition/downward pricing pressure, lowered test-strip reimbursement, and market saturation of lower-cost meters, among other factors.

According to the International Diabetes Federation (IDF), approximately 425 million adults (20-79 years of age) have diabetes worldwide, and this number is expected to rise nearly 50% to approximately 629 million by 2045. More than 1.25 million people have type 1 diabetes in the US alone.

This comprehensive medical market and technology report covers:

Blood glucose monitoring is essential for people with diabetes to lower the risk of complications. It is particularly important for those with type 1 diabetes, but also in people with type 2 diabetes who frequently administer insulin and/or suffer from symptomatic blood sugar fluctuations.

Blood glucose monitoring devices include both traditional handheld blood glucose meters (BGMs) used by patients at home and by healthcare practitioners at the point-of-care, and new sophisticated continuous glucose monitoring systems (CGMs) used by type 1 and insulin-dependent type 2 diabetics.

The overall BGMDs market is being driven by several positive factors, including:

Key Topics Covered:

1. Diabetes Overview

1.1 Prevalence

1.2 Diabetes defined

1.2.1 Symptoms

1.2.2 Complications

1.2.3 Diagnosis and treatment

1.2.4 Cost of diabetes

1.3 Bibliography

2. Blood Glucose Monitoring Devices

2.1 Blood glucose meters

2.1.1 Abbott

2.1.2 Ascensia Diabetes Care

2.1.3 LifeScan/Platinum Equity

2.1.4 Roche

2.1.5 Livongo

2.1.6 One Drop/Apple Watch

2.2 Continuous blood glucose monitoring systems

2.2.1 Abbott

2.2.2 Dexcom

2.2.3 Medtronic

2.3 New or emerging wearable blood glucose monitoring patches

2.3.1 Medtronic: glucose-sensing patch

2.3.2 Nemaura Medical

2.3.3 Senseonics

2.3.4 Verily

2.4 Diabetes monitoring mobile apps

2.5 Bibliography

3. Market Analysis

3.1 Blood glucose monitoring devices market

3.1.1 Market forecast: global

3.1.2 Market forecast: by region and segment

3.1.3 US market

3.1.4 Five major EU markets

3.1.5 Japanese market

3.1.6 Rest of the world market

3.1.7 Market drivers and limiters

3.2 Competitive analysis

3.2.1 Market share: global/combined

3.2.2 Market share: by segment

3.2.3 Market share: by region

3.3 Corporate profiles

3.3.1 Abbott

3.3.2 Ascensia Diabetes Care

3.3.3 Dexcom

3.3.4 Medtronic

3.3.5 Nemaura Medical

3.3.6 Roche

3.3.7 Senseonics

3.4 Bibliography

For more information about this report visit https://www.researchandmarkets.com/r/9r4sw0

View source version on businesswire.com:https://www.businesswire.com/news/home/20200204005885/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 02/04/2020 01:02 PM/DISC: 02/04/2020 01:02 PM